Q3 EPS Estimate for Option Care Health Decreased by Analyst

Key Points

• William Blair has cut its Q3 2025 earnings per share estimate for Option Care Health from $0.39 to $0.38, while maintaining a full-year earnings estimate of $1.22 per share.
• Option Care Health reported a quarterly earnings per share of $0.41, exceeding the consensus estimate of $0.40, alongside revenue of $1.42 billion, which is above the projected $1.35 billion.
• Despite the earnings downgrade, Option Care Health has received upgrades from multiple analysts, with a current consensus rating of "Moderate Buy" and an average target price of $35.75 for its stock.

Option Care Health, Inc. (NASDAQ:OPCH - Free Report) - Stock analysts at William Blair lowered their Q3 2025 earnings per share (EPS) estimates for Option Care Health in a report issued on Wednesday, July 30th. William Blair analyst M. Larew now forecasts that the company will post earnings of $0.38 per share for the quarter, down from their prior estimate of $0.39. The consensus estimate for Option Care Health's current full-year earnings is $1.22 per share. William Blair also issued estimates for Option Care Health's Q4 2026 earnings at $0.50 EPS.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The company's quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.30 EPS.

Several other analysts also recently weighed in on the company. Barrington Research restated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research note on Thursday, July 10th. JMP Securities raised their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $35.75.

Option Care Health Stock Down 0.8%

Shares of NASDAQ:OPCH traded down $0.23 during midday trading on Monday, hitting $27.68. 560,165 shares of the stock were exchanged, compared to its average volume of 1,852,560. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. Option Care Health has a 52-week low of $21.39 and a 52-week high of $35.53. The business's fifty day simple moving average is $30.82 and its two-hundred day simple moving average is $31.94. The company has a market capitalization of $4.49 billion, a PE ratio of 22.14, a P/E/G ratio of 1.78 and a beta of 0.79.

Hedge Funds Weigh In On Option Care Health

A number of hedge funds have recently bought and sold shares of the company. JPMorgan Chase & Co. grew its stake in shares of Option Care Health by 29.6% in the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock worth $35,065,000 after acquiring an additional 344,875 shares in the last quarter. Pictet Asset Management Holding SA boosted its holdings in Option Care Health by 12.8% in the 4th quarter. Pictet Asset Management Holding SA now owns 32,885 shares of the company's stock worth $763,000 after buying an additional 3,738 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in Option Care Health by 121.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 142,441 shares of the company's stock worth $3,305,000 after purchasing an additional 78,240 shares in the last quarter. Alliancebernstein L.P. increased its holdings in Option Care Health by 4.5% during the 4th quarter. Alliancebernstein L.P. now owns 586,699 shares of the company's stock worth $13,611,000 after acquiring an additional 25,054 shares during the period. Finally, ExodusPoint Capital Management LP increased its stake in Option Care Health by 167.8% in the 4th quarter. ExodusPoint Capital Management LP now owns 54,810 shares of the company's stock worth $1,272,000 after acquiring an additional 34,340 shares during the last quarter. Institutional investors own 98.05% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.